As part of the Discovery Grant Program 2022 from the ALS Society of Canada and the Brain Canada Foundation, with support from the Fund Dr. Jean-Pierre Canuel – ALS Québec selected three research projects conducted by the University of Montreal School of Medicine to advance knowledge that will improve the diagnosis of Amyotrophic Lateral Sclerosis (ALS) and the treatment of people living with the disease.
A total of nine Discovery Grants worth more than $1.4 million were awarded to multidisciplinary research teams from across Canada.
Here are the three UdeM Faculty of Medicine projects funded by the 2022 Discovery Grants.
Project: Could the study of neuromuscular synapse proteins contribute to the development of essential biomarkers?
dr Richard Robitaille, Full Professor at the Department of Neuroscience at UdeM, in collaboration with Drs. Danielle Arbor and Roberta Piovesana from the same department and Dr. Robert Bowser of the Barrow Neurological Institute for $300,000 in funding.
Project: Could axon protection represent a promising treatment strategy for ALS?
dr Alex Parker, full professor at the Department of Neurosciences at UdeM and researcher at the CHUM Research Center, in collaboration with Dr. Gary Armstrong of McGill University for a $300,000 grant.
Project: What role does its sister protein play in restoring G3BP1 levels as a potential ALS treatment strategy?
dr Christine Vande Velde, full professor in the Department of Neurosciences at UdeM and researcher at the CHUM Research Center, in collaboration with Dr. Marlene Oeffinger, an associate professor in the University’s Department of Biochemistry and Molecular Medicine and a researcher at the Montreal Clinical Research Institute, will receive $125,000 in funding.
Source: ALS Canada.